ALS TDI on NBC's Today Show
“Six years ago, ALS TDI began banking movement and voice samples from ALS patients, in the hope that one day, technology could help turn that data into a cure” says NBC reporter Natalie Morales. ALS TDI’s CSO Fernando Vieira is quoted, “We formed this database in hopes that someday, somebody would come along and care. And it turned out, that Google came along and cared”.
As part of their Project Euphonia, Google has provided the means to identify and track progression of the disease, but more importantly, to provide the ability to use the individual’s own voice to drive a speech synthesizer so as the disease progresses, they can still sound like themselves and not like Stephen Hawking did.
Steve has been CEO of ALS TDI since 2009, developing an understanding of, and potential cures for, the neurodegenerative disease. He is now building out a new team as Anelixis Therapeutics to develop one of the more promising drugs to come out of the lab. It has potential for not only ALS, but many other indications in the auto-immune suppression space.
“Led by drug development experts and people with ALS, our Cambridge, Massachusetts based lab is funded by a global network of supporters unified to end ALS. Our mission is to discover and develop effective treatments for ALS.”
About the CEO Roundtable
It doesn’t have to be lonely at the top! Our Boston-based CEO Roundtable brings CEOs, Presidents and business owners together for confidential, candid, solution-seeking discussions that focus on the challenges and pressures unique to top-level management.
CEO Roundtable is made up of private, peer advisory groups of 8 to 12 members from non-competing companies. These peer groups provide a forum for invigorating exchanges of information, ideas, and insights.